Augusto Villanueva Rodriguez, MD, PhD
img_Augusto Villanueva Rodriguez
ASSOCIATE PROFESSOR | Medicine, Liver Diseases
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Are you a patient?
Gastroenterology, Internal Medicine
Research Topics
Cancer, Liver
Multi-Disciplinary Training Area
Cancer Biology [CAB]

MD, University of Santiago de Compostela

MD, Universidad Santiago de Compostela

Residence, Gastroenterology & Hepatology, University Hospital of Santiago de Compostela

PhD, Biomedical Research, University of Santiago de Compostela

MS, Research in Liver Diseases, University of Barcelona

Residency, Transplant Hepatology, University of Santiago de Compostela


Junior Faculty Award

GE Liver Gene Expression


Alan Hofmann Clinical and Translational Award in Liver Diseases

American Association for the Study of Liver Diseases Foundation


Rising Star Gastroenterologist, United European Gastroenterology


Sheila Sherlock Fellowship, European Association for the Study of the Liver


Juan Rodes Award, Asociacion Española para el Estudio del Higado


Pedro Barrie de la Maza Fellow, Foundation Banco Pastor


National Award for Excellence in Academic Performance, Ministry of Edication (Goverment of Spain)


Selected Publications

Biomarkers for immunotherapy of hepatocellular carcinoma. Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, Benjamin Ruf, Mark Yarchoan, Lichun Ma, Eytan Ruppin, Xin W. Wang. Nature Reviews Clinical Oncology

WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma. Alex Rialdi, Mary Duffy, Alex P. Scopton, Frank Fonseca, Julia Nanyi Zhao, Megan Schwarz, Pedro Molina-Sanchez, Slim Mzoughi, Elisa Arceci, Jordi Abril-Fornaguera, Austin Meadows, Marina Ruiz de Galarreta, Denis Torre, Kyna Reyes, Yan Ting Lim, Felix Rosemann, Zaigham M. Khan, Kevin Mohammed, Xuedi Wang, Xufen Yu, Manikandan Lakshmanan, Ravisankar Rajarethinam, Soo Yong Tan, Jian Jin, Augusto Villanueva, Eleftherios Michailidis, Ype P. De Jong, Charles M. Rice, Ivan Marazzi, Dan Hasson, Josep M. Llovet, Radoslaw M. Sobota, Amaia Lujambio, Ernesto Guccione, Arvin C. Dar. Nature Cancer

Sublethal necroptosis signaling promotes inflammation and liver cancer. Mihael Vucur, Ahmed Ghallab, Anne T. Schneider, Arlind Adili, Mingbo Cheng, Mirco Castoldi, Michael T. Singer, Veronika Büttner, Leonie S. Keysberg, Lena Küsgens, Marlene Kohlhepp, Boris Görg, Suchira Gallage, Jose Efren Barragan Avila, Kristian Unger, Claus Kordes, Anne Laure Leblond, Wiebke Albrecht, Sven H. Loosen, Carolin Lohr, Markus S. Jördens, Anne Babler, Sikander Hayat, David Schumacher, Maria T. Koenen, Olivier Govaere, Mark V. Boekschoten, Simone Jörs, Carlos Villacorta-Martin, Vincenzo Mazzaferro, Josep M. Llovet, Ralf Weiskirchen, Jakob N. Kather, Patrick Starlinger, Michael Trauner, Mark Luedde, Lara R. Heij, Ulf P. Neumann, Verena Keitel, Johannes G. Bode, Rebekka K. Schneider, Frank Tacke, Bodo Levkau, Twan Lammers, Georg Fluegen, Theodore Alexandrov, Amy L. Collins, Glyn Nelson, Fiona Oakley, Derek A. Mann, Christoph Roderburg, Thomas Longerich, Achim Weber, Augusto Villanueva, Andre L. Samson, James M. Murphy, Rafael Kramann, Fabian Geisler, Ivan G. Costa, Jan G. Hengstler, Mathias Heikenwalder, Tom Luedde. Immunity

View All Publications

Hepatocellular Carcinoma: New Therapies and Challenges
Update in the Clinical Management of Hepatocellular Carcinoma

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Villanueva Rodriguez during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Genentech, Inc.
  • Astrazeneca
  • Espervita
  • NGM Pharmaceuticals
  • Eisai, Inc.
  • Pioneering Medicine
  • First Word
  • Elevar Therapeutics

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Espervita

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.